Psychotropic Medication and Psychotropic Polypharmacy Among Children and Adolescents in the US Child Welfare System

Laura F Radel; Mir M Ali; Kristina West; Sarah A Lieff

doi:10.1001/jamapediatrics.2023.3068

Psychotropic Medication and Psychotropic Polypharmacy Among Children and Adolescents in the US Child Welfare System

JAMA Pediatr. 2023 Oct 1;177(10):1107-1110. doi: 10.1001/jamapediatrics.2023.3068.

Authors

Laura F Radel¹, Mir M Ali¹, Kristina West¹, Sarah A Lieff²

Affiliations

¹ Office of the Assistant Secretary for Planning and Evaluation, US Department of Health and Human Services, Washington, DC.
² Mathematica, Washington, DC.

No abstract available

Plain language summary

This cross-sectional study evaluates rates of psychotropic medication and polypharmacy use among youths in the US child welfare system compared with other youths with Medicaid coverage in 2019.

MeSH terms

Adolescent
Child
Child Welfare
Child, Preschool
Female
Humans
Male
Mental Disorders / drug therapy
Polypharmacy*
Psychotropic Drugs* / administration & dosage
Psychotropic Drugs* / therapeutic use
United States

Substances

Psychotropic Drugs